9 employees
Brevitest Technologies is a developer of a point-of-care medical device to assist enzyme immunoassays for early-stage detection of diseases.
2013
$15K
from 1 investors over 1 rounds
Brevitest Technologies, Inc. raised $15K on May 16, 2015
Investors: Texas A&M New Ventures Competition